Bridgefront Capital’s MiMedx Group MDXG Stock Holding History

Bridgefront Capital’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-17,010	Closed	-$131K	–	597
2024 Q1	$131K	Buy	+17,010	New	+$137K	0.1%	343

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bridgefront Capital's MDXG Position: Q2 2024 in Review

Bridgefront Capital sold out of MiMedx Group (MDXG) in Q2 2024, closing a stake of 17,010 shares — an estimated $131K sold.

Bridgefront Capital first reported a position in MDXG in Q1 2024 and held it in 1 quarter. The position peaked at $131K in Q1 2024. 202 funds tracked by Wall St. Rank hold MDXG as of Q2 2024.

Bridgefront Capital reported no remaining MiMedx Group position as of Q2 2024 after selling out during the quarter.
Bridgefront Capital sold 17,010 MiMedx Group shares in Q2 2024, an estimated $131K.
Bridgefront Capital first reported a position in MiMedx Group in Q1 2024 and held it in 1 quarter.
Bridgefront Capital's MiMedx Group position peaked at $131K in Q1 2024.
202 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2024.

Based on Bridgefront Capital's 13F filing for Q2 2024, filed 14 Aug 2024.